Cashu
NovaBay Pharmaceuticals Sells Avenova Business for $11.5 Million Amid Strategic Restructuring
10 months ago
Stocks
Health Care
nby
Novabay Pharmaceuticals
NYSE MKT LLC: NBY
-0.08 (-6.82%)
1.025
USD
At close at Nov 14, 21:38 UTC
Overview
Loading chart...
Key Stats
Market Cap
6.00M
Dividend Yield
0.00%
P/E Ratio
1.85
EPS
-30.48
Revenue
7.15M
Avg. Volume
152.14K
About
What does NBY do?
NovaBay Pharmaceuticals, based in Emeryville, California, specializes in eyecare and wound care products, including the Avenova line and hypochlorous acid solutions for various medical applications. The company went public on October 26, 2007, and employs 24 staff members.
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.